Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Non-cash Items (2023 - 2025)

Abeona Therapeutics has reported Non-cash Items over the past 4 years, most recently at $5000.0 for Q4 2025.

  • Quarterly results put Non-cash Items at $5000.0 for Q4 2025, down 16.67% from a year ago — trailing twelve months through Dec 2025 was $5000.0 (down 16.67% YoY), and the annual figure for FY2025 was $5000.0, down 16.67%.
  • Non-cash Items for Q4 2025 was $5000.0 at Abeona Therapeutics, down from $174792.0 in the prior quarter.
  • Over the last five years, Non-cash Items for ABEO hit a ceiling of $174792.0 in Q3 2025 and a floor of $1000.0 in Q2 2024.
  • Median Non-cash Items over the past 3 years was $6000.0 (2024), compared with a mean of $55525.3.
  • Peak annual rise in Non-cash Items hit 500.0% in 2025, while the deepest fall reached 97.92% in 2025.
  • Abeona Therapeutics' Non-cash Items stood at $3000.0 in 2023, then skyrocketed by 100.0% to $6000.0 in 2024, then decreased by 16.67% to $5000.0 in 2025.
  • The last three reported values for Non-cash Items were $5000.0 (Q4 2025), $174792.0 (Q3 2025), and $6000.0 (Q2 2025) per Business Quant data.